Cytogenetic and molecular aspects of lung cancer.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Letters

• Publication date

  2006-07-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CANLET.2005.06.030PMID 16112428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statistical dissection of cytogenetic patterns in lung cancer reveals multiple modes of karyotypic evolution independent of histological classification.

  2004cited by this paper
• Molecular oncology--perspectives in lung cancer.

  2004cited by this paper
• Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer.

  2004cited by this paper
• Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients.

  2004cited by this paper
• Validation of molecular and immunological factors with predictive importance in lung cancer.

  2004cited by this paper
• The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature

  2003cited by this paper
• Investigation of c-myc and p53 Gene Alterations in the Tumor and Surgical Borderline Tissues of NSCLC and Effects on Clinicopathologic Behavior: By the FISH Technique

  2003cited by this paper
• The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer.

  2003cited by this paper
• HER‐2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma

  2002cited by this paper
• Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers

  2002cited by this paper
• Chromosomal alterations in small cell lung cancer revealed by multicolour fluorescence in situ hybridization

  2002cited by this paper
• The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

  2002cited by this paper
• Chromosomal imbalances of primary and metastatic lung adenocarcinomas

  2002cited by this paper
• Chromosomal imbalances in human lung cancer

  2002cited by this paper
• Tobacco use and cancer: an epidemiologic perspective for geneticists

  2002cited by this paper
• Cytogenetics and molecular genetics of lung cancer.

  2002cited by this paper
• Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.

  2001cited by this paper
• Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.

  2001cited by this paper
• Molecular abnormalities in lung carcinogenesis and their potential clinical implications.

  2001cited by this paper
• Molecular and cytogenetic alterations in early stage of carcinogenesis of human lung.

  2001cited by this paper
• Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas

  2001cited by this paper
• Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II.

  2001cited by this paper
• Clinical significance of the Rb expression in adenocarcinoma of the lung.

  2001cited by this paper
• Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.

  2001cited by this paper
• p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients.

  2000cited by this paper
• A broad amplification pattern at 3q in squamous cell lung cancer--a fluorescence in situ hybridization study.

  2000cited by this paper
• Frequent chromosome 8q gains in human small cell lung carcinoma detected by arbitrarily primed-PCR genomic fingerprinting.

  2000cited by this paper
• High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.

  2000cited by this paper
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3

  2000cited by this paper
• Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies.

  2000cited by this paper
• K-ras gene mutations in non-small cell lung cancer in Japanese.

  2000cited by this paper
• Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer.

  2000cited by this paper
• Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.

  2000cited by this paper
• Predicting lung cancer by detecting aberrant promoter methylation in sputum.

  2000cited by this paper
• Analysis of Chromosomal Alterations in Non-Small Cell Lung Cancer by Multiplex-FISH, Comparative Genomic Hybridization, and Multicolor Bar Coding

  2000cited by this paper
• Molecular and genetic aspects of lung cancer.

  2000cited by this paper
• Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.

  1999cited by this paper
• The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control.

  1999cited by this paper
• Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer

  1999cited by this paper
• Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer.

  1999cited by this paper
• K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases.

  1999cited by this paper
• Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma

  1999cited by this paper
• Chromosome 3 imbalances are the most frequent aberration found in non-small cell lung carcinoma.

  1999cited by this paper
• Amplification of the C-MYC Oncogene in Non-small Cell Lung Cancer

  1999cited by this paper
• Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

  1998cited by this paper
• Association between cigarette smoking and FHIT gene alterations in lung cancer.

  1997cited by this paper
• Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes.

  1997cited by this paper
• Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung.

  1997cited by this paper
• Homozygous deletions of human chromosome 3p in lung tumors.

  1997cited by this paper
• FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

  1997cited by this paper
• Altered retinoblastoma protein expression in nonsmall cell lung cancer

  1997cited by this paper
• Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p.

  1997cited by this paper
• Advances in the analysis of chromosome alterations in human lung carcinomas.

  1997cited by this paper
• The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer

  1996cited by this paper
• Late occurrence of K-ras gene mutations in the pathogenesis of squamous cell carcinoma of the lung: analysis in sputum.

  1996cited by this paper
• Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis.

  1996cited by this paper
• Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin.

  1996cited by this paper
• Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.

  1995cited by this paper
• Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.

  1995cited by this paper
• Importance of chromosome 9p loss in human lung cancer.

  1995cited by this paper
• Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer.

  1995cited by this paper
• Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.

  1995cited by this paper
• K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas.

  1994cited by this paper
• Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization.

  1994cited by this paper
• c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung.

  1994cited by this paper
• Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.

  1994cited by this paper
• Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

  1993cited by this paper
• Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas.

  1992cited by this paper
• Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.

  1991cited by this paper
• myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens.

  1991cited by this paper
• Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).

  1982cited by this paper

• Vaping, Environmental Toxicants Exposure, and Lung Cancer Risk

  2023cites this paper
• Precision Targeting of Non-Small Cell Lung Cancer: Identifying Optimal Drug Targets and FDA-Approved Combinations for Enhanced Therapeutic Efficacy

  2023cites this paper
• Synthetic Evaluation of MicroRNA-1-3p Expression in Head and Neck Squamous Cell Carcinoma Based on Microarray Chips and MicroRNA Sequencing

  2021cites this paper
• Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells

  2021influential citation
• Inhibition of pyruvate dehydrogenase kinase redirects NSCLC cell metabolism and counteracts development of resistance to epidermal growth factor receptor tyrosine kinase inhibitors

  2020cites this paper
• Mechanisms of Fritillariae Thunbergii Flos in Lung Cancer Treatment from a Systems Pharmacology Perspective.

  2020cites this paper
• Lung Cancers and the Roles of Natural Compounds as Potential Chemotherapeutic and Chemopreventive Agents

  2019cites this paper
• CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification

  2019cites this paper
• Increased expression of LINC01510 predicts poor prognosis and promotes malignant progression in human non-small cell lung cancer.

  2019cites this paper
• A Case Of Neuroendocrine Carcinoma Expressing Myeloid Markers By Flow Cytometry And Review Of the Literature

  2018cites this paper
• MicroRNA-associated carcinogenesis in lung carcinoma

  2018cites this paper
• Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells.

  2017cites this paper
• Development of crizotinib, a rationally designed tyrosine kinase inhibitor for non‐small cell lung cancer

  2017cites this paper
• Downregulation of Cited 1 suppresses cell proliferation by inducing G 2 / M arrest of the cell cycle in non-small-cell lung cancer cell lines

  2016cites this paper
• Title : A case of neuroendocrine carcinoma expressing myeloid markers by flow cytometry and review of the literature Running Title : Neuroendocrine carcinoma expressing myeloid markers

  2016cites this paper
• Signalisation nucléaire de l'IGF-1R et résistance aux thérapies anti-EGFR dans les cancers du poumon

  2016cites this paper
• Traitement du cancer pulmonaire non à petites cellules par radiothérapie stéréotaxique d’ablation

  2016cites this paper
• Pathway Crosstalk Analysis of Microarray Gene Expression Profile in Human Hepatocellular Carcinoma

  2015cites this paper
• Tumors of the lung

  2015cites this paper
• Gene Silencing Associated with SWI/SNF Complex Loss during NSCLC Development

  2014cites this paper
• Relationship between uptake of a radioiodinated quinazoline derivative and radiosensitivity in non-small cell lung cancer.

  2014cites this paper
• BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.

  2014cites this paper
• Cancer of the Lung: Non–Small Cell Lung Cancer and Small Cell Lung Cancer

  2014cites this paper
• The effects of a cigarette carcinogen on glucocorticoid receptor methylation.

  2014influential citation
• Vergleichende Analyse genomischer Aberrationen in Primärtumoren und Hirnmetastasen von Karzinompatienten

  2014cites this paper
• Original research-Orijinal araştırma

  2014cites this paper
• The Involvement of NRF2 in Lung Cancer

  2013cites this paper
• Glucocorticoid receptor promoter expression and apoptosis induction in small cell lung cancer.

  2013influential citation
• Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer

  2013cites this paper
• Status of hepatitis C virus infection in lung cancer patients

  2013cites this paper
• Towards personalized medicine using systems biology and machine learning

  2013cites this paper
• Diagnostic value of the FHIT and p16 mRNA loss and the K-ras gene mutation in pleural fluids for malignant pleural effusion

  2013cites this paper
• Efficacy of two fluorescence in situ hybridization (FISH) probes for diagnosing malignant pleural effusions.

  2013cites this paper
• Epigentic silencing of the glucocorticoid receptor in small cell lung cancer cells.

  2013cites this paper
• INHIBITION OF LUNG TUMORIGENESIS AND CANCER CELL GROWTH BY EGCG AND OTHER CHEMOPREVENTIVE AGENTS by

  2013cites this paper
• T-Oligo and its Associated Proteins in Apoptosis and Senescence

  2012influential citation
• Interplay between microRNA-21 and Sprouty2 in non small cell lung cancer-derived cell lines

  2012influential citation
• A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens

  2012cites this paper
• ITGA11 (integrin, alpha 11)

  2011cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2011cites this paper
• Impact on Disease Development, Genomic Location and Biological Function of Copy Number Alterations in Non-Small Cell Lung Cancer

  2011cites this paper
• CTLA4 gene variations and haplotypes in patients with lung cancer.

  2010cites this paper
• Prognostic value of trisomy 8 in primary myelodysplastic syndrome

  2010cites this paper
• Short communication CTLA4 gene variations and haplotypes in patients with lung cancer

  2010cites this paper
• Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?

  2010cites this paper
• Monosomy 12 and deletion of 13q34 in a case of chronic lymphocytic leukemia with concomitant lung cancer.

  2010cites this paper
• The natural tumor suppressor protein maspin and potential application in non small cell lung cancer.

  2010cites this paper
• Molecular Alterations in Asbestos-Related Lung Cancer

  2010cites this paper
• Establishment and characterization of a new drug surviving cell line Am1010, derived directly from muscle metastases of a human lung adenocarcinoma patient with multi-drug-resistance to cisplatin, taxol, and gefitinib

  2010cites this paper
• Stem cells and lung cancer: future therapeutic targets?

  2009cites this paper
• Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer.

  2009cites this paper
• Lung Cancer: Overview

  2009cites this paper
• Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy.

  2009cites this paper
• ASPECTS EPIGENETIQUES DES CANCERS BRONCHO-PULMONAIRES & IMPLICATION DE L'HISTONE ACETYLTRANSFERASE Tip60

  2009cites this paper
• Stemcellsandlungcancer: future therapeutictargets?

  2009cites this paper
• Genetic alterations and lineage specificity in lung cancer

  2009cites this paper
• radon-induites chez le rat

  2009cites this paper
• NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.

  2009cites this paper
• Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review).

  2009cites this paper
• Caractérisation moléculaire de tumeurs pulmonaires radon-induites chez le rat

  2008cites this paper
• Expressão da proteína erbB-3/HER3 em câncer de pulmão pela técnica de imuno-histoquímica e sua correlação com características clínicopatológicas

  2008cites this paper
• Integrative genomic and gene expression analysis of chromosome 7 identified novel oncogene loci in non-small cell lung cancer.

  2008cites this paper
• 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.

  2008cites this paper
• Current status of clinical trials for small cell lung cancer.

  2008cites this paper
• A systems biology approach for pathway level analysis data

  2007cites this paper
• Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis

  2007cites this paper
• FRMD3, a novel putative tumour suppressor in NSCLC

  2007cites this paper
• DNA methylation in states of cell physiology and pathology.

  2007cites this paper
• A systems biology approach for pathway level analysis.

  2007cites this paper
• Understanding tobacco smoke carcinogen NNK and lung tumorigenesis.

  2006cites this paper
• Micronúcleos em células tumorais: biologia e implicações para a tumorigênese

  2006cites this paper